Core Scientific [CORZ] vs Klaviyo [KVYO] Detailed Stock Comparison
Core Scientific
NASDAQ
Loading...
Klaviyo
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 17 vital metrics comparison: Core Scientific wins in 5 metrics, Klaviyo wins in 12 metrics, with 0 ties. Klaviyo appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Core Scientific | Klaviyo | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -3.09 | -179.00 | Klaviyo |
| Price-to-Book Ratio | -4.05 | 8.75 | Core Scientific |
| Debt-to-Equity Ratio | -1.09 | 9.04 | Core Scientific |
| PEG Ratio | 0.03 | -0.51 | Klaviyo |
| EV/EBITDA | -86.45 | -96.17 | Klaviyo |
| Profit Margin (TTM) | 23.71% | -6.19% | Core Scientific |
| Operating Margin (TTM) | -28.13% | -10.69% | Klaviyo |
| Return on Equity | 160.33% | -6.42% | Core Scientific |
| Return on Assets (TTM) | -6.74% | -5.05% | Klaviyo |
| Free Cash Flow (TTM) | $-52.30M | $148.73M | Klaviyo |
| 1-Year Return | 25.93% | 0.28% | Core Scientific |
| Price-to-Sales Ratio (TTM) | 11.88 | 8.91 | Klaviyo |
| Enterprise Value | $4.72B | $8.77B | Klaviyo |
| EV/Revenue Ratio | 13.55 | 8.13 | Klaviyo |
| Gross Profit Margin (TTM) | 6.39% | 75.70% | Klaviyo |
| Revenue per Share (TTM) | $1 | $4 | Klaviyo |
| Earnings per Share (Diluted) | $-1.73 | $-0.24 | Klaviyo |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Core Scientific vs Klaviyo Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Core Scientific | -1.74% | -4.10% | 0.52% | 25.12% | 37.42% | -6.42% |
| Klaviyo | 2.47% | 4.26% | 0.06% | -2.76% | -21.17% | -21.30% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Core Scientific | 25.93% | 291.62% | 291.62% | 291.62% | 291.62% | 291.62% |
| Klaviyo | 0.28% | -1.86% | -1.86% | -1.86% | -1.86% | -1.86% |
Performance & Financial Health Analysis: Core Scientific vs Klaviyo
| Metric | CORZ | KVYO |
|---|---|---|
| Market Information | ||
| Market Cap | $4.14B | $9.61B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 22,691,300 | 3,615,530 |
| 90 Day Avg. Volume | 17,220,423 | 2,018,393 |
| Last Close | $13.55 | $32.77 |
| 52 Week Range | $6.20 - $18.63 | $23.77 - $49.55 |
| % from 52W High | -27.26% | -33.86% |
| All-Time High | $18.63 (Nov 25, 2024) | $49.55 (Feb 10, 2025) |
| % from All-Time High | -27.27% | -33.86% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.44% | 0.32% |
| Quarterly Earnings Growth | -0.44% | 0.32% |
| Financial Health | ||
| Profit Margin (TTM) | 0.24% | -0.06% |
| Operating Margin (TTM) | -0.28% | -0.11% |
| Return on Equity (TTM) | 1.60% | -0.06% |
| Debt to Equity (MRQ) | -1.09 | 9.04 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $-3.51 | $3.66 |
| Cash per Share (MRQ) | $1.90 | $3.12 |
| Operating Cash Flow (TTM) | $12.92M | $168.96M |
| Levered Free Cash Flow (TTM) | $-125,378,624 | $186.32M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Core Scientific vs Klaviyo
| Metric | CORZ | KVYO |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -3.09 | -179.00 |
| Forward P/E | 43.71 | 57.18 |
| PEG Ratio | 0.03 | -0.51 |
| Price to Sales (TTM) | 11.88 | 8.91 |
| Price to Book (MRQ) | -4.05 | 8.75 |
| Market Capitalization | ||
| Market Capitalization | $4.14B | $9.61B |
| Enterprise Value | $4.72B | $8.77B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 13.55 | 8.13 |
| Enterprise to EBITDA | -86.45 | -96.17 |
| Risk & Other Metrics | ||
| Beta | N/A | N/A |
| Book Value per Share (MRQ) | $-3.51 | $3.66 |
Financial Statements Comparison: Core Scientific vs Klaviyo
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | CORZ | KVYO |
|---|---|---|
| Revenue/Sales | $79.53M | $293.12M |
| Cost of Goods Sold | $71.31M | $71.24M |
| Gross Profit | $8.21M | $221.88M |
| Research & Development | N/A | $72.46M |
| Operating Income (EBIT) | $-42.59M | $-31.33M |
| EBITDA | $-641.64M | $-27.40M |
| Pre-Tax Income | $580.90M | $-22.48M |
| Income Tax | $205,000 | $1.80M |
| Net Income (Profit) | $580.69M | $-24.28M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | CORZ | KVYO |
|---|---|---|
| Cash & Equivalents | $697.94M | $888.43M |
| Total Current Assets | $833.18M | $1.01B |
| Total Current Liabilities | $195.51M | $192.82M |
| Long-Term Debt | $1.17B | $84.12M |
| Total Shareholders Equity | $-181.51M | $1.06B |
| Retained Earnings | $-3.15B | $-859.27M |
| Property, Plant & Equipment | $610.44M | $90.82M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | CORZ | KVYO |
|---|---|---|
| Operating Cash Flow | $590.74M | $36.85M |
| Capital Expenditures | $-88.42M | $-2.69M |
| Free Cash Flow | $-129.06M | $6.62M |
| Debt Repayment | $-4.46M | $0 |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | CORZ | KVYO |
|---|---|---|
| Shares Short | 57.61M | 5.50M |
| Short Ratio | 2.57 | 4.80 |
| Short % of Float | 0.19% | 0.05% |
| Average Daily Volume (10 Day) | 22,691,300 | 3,615,530 |
| Average Daily Volume (90 Day) | 17,220,423 | 2,018,393 |
| Shares Outstanding | 292.61M | 272.76M |
| Float Shares | 295.64M | 4.99M |
| % Held by Insiders | 0.07% | 0.00% |
| % Held by Institutions | 0.94% | 1.10% |
Dividend Analysis & Yield Comparison: Core Scientific vs Klaviyo
| Metric | CORZ | KVYO |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |